We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
-11.68%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$2.05B
AUM Growth
-$991M
Cap. Flow
-$585M
Cap. Flow %
-28.51%
Top 10 Hldgs %
64.04%
Holding
87
New
11
Increased
8
Reduced
58
Closed
9

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$52.2M
2
MPC icon
Marathon Petroleum
MPC
+$15.1M
3
MPT
Medical Properties Trust
MPT
+$10.9M
4
CVNA icon
Carvana
CVNA
+$10.6M
5
SNAP icon
Snap
SNAP
+$9.76M

Sector Composition

Rank Sector Weight
1 Financials 33.02%
2 Consumer Discretionary 14.31%
3 Technology 10.25%
4 Communication Services 9.06%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLW icon
51
Clearwater Paper
CLW
$281M
$4.47M 0.22%
183,307
-11,693
-6% -$315K
CI icon
52
Cigna
CI
$77.3B
$4.45M 0.22%
+23,436
New +$4.89M
CPB icon
53
Campbell Soup
CPB
$6.69B
$4.4M 0.21%
133,254
-8,596
-6% -$325K
ADVM
54
DELISTED
Adverum Biotechnologies
ADVM
$4.05M 0.2%
128,540
+13,540
+12% +$551K
MHK icon
55
Mohawk Industries
MHK
$7.03B
$3.92M 0.19%
33,471
-5,134
-13% -$685K
BOLD
56
DELISTED
Audentes Therapeutics, Inc
BOLD
$3.56M 0.17%
166,890
-74,110
-31% -$1.91M
WVE icon
57
Wave Life Sciences
WVE
$1.15B
$3.3M 0.16%
78,394
-33,606
-30% -$1.49M
HA
58
DELISTED
Hawaiian Holdings, Inc.
HA
$3.3M 0.16%
124,820
-17,039
-12% -$577K
URBN icon
59
Urban Outfitters
URBN
$6.23B
$3.25M 0.16%
+97,764
New +$3.66M
MU icon
60
CALL
Micron Technology
MU
$1.01T
$3.17M 0.15%
100,000
-870,000
-90% -$33M
AUD
61
DELISTED
Audacy, Inc.
AUD
$2.67M 0.13%
467,493
-29,817
-6% -$198K
CVNA icon
62
PUT
Carvana
CVNA
$45.5B
$2.55M 0.12%
389,500
-110,500
-22% -$930K
AMRS
63
DELISTED
Amyris Inc.
AMRS
$2.1M 0.1%
+629,104
New +$3.62M
BLUE
64
DELISTED
bluebird bio
BLUE
$2.03M 0.1%
1,578
-1,019
-39% -$1.56M
QURE icon
65
uniQure
QURE
$2.67B
$1.97M 0.1%
68,400
-45,100
-40% -$1.25M
SGMO
66
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.69M 0.08%
146,740
-96,260
-40% -$1.2M
BABA icon
67
Alibaba
BABA
$274B
$1.62M 0.08%
11,800
-78,200
-87% -$11.6M
CLLS
68
Cellectis
CLLS
$286M
$1.54M 0.08%
92,793
-60,766
-40% -$1.41M
ONCE
69
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.49M 0.07%
38,130
-25,270
-40% -$1.1M
SLDB icon
70
Solid Biosciences
SLDB
$789M
$1.29M 0.06%
3,215
-2,098
-39% -$986K
GG
71
DELISTED
Goldcorp Inc
GG
$1.29M 0.06%
131,701
-6,804
-5% -$66K
RARE icon
72
Ultragenyx Pharmaceutical
RARE
$2.67B
$1.26M 0.06%
28,972
-25,128
-46% -$1.37M
ADAP
73
DELISTED
Adaptimmune Therapeutics
ADAP
$1.21M 0.06%
210,459
-86,324
-29% -$637K
ABEO icon
74
Abeona Therapeutics
ABEO
$351M
$1.2M 0.06%
6,726
-4,394
-40% -$958K
EDIT icon
75
Editas Medicine
EDIT
$416M
$1.2M 0.06%
52,514
-34,251
-39% -$932K

Similar funds

WS Management's Q4 2018 Portfolio in Review

As of Q4 2018, WS Management held 87 positions worth $2.05B, down 33% from $3.05B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

WS Management withdrew a net $585M in Q4 2018, closing 9 positions and reducing 58 holdings. Its most notable exit was The Mosaic Company, an estimated $35.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, WS Management opened a new position in Marathon Petroleum worth $13M.

  • WS Management's largest Q4 2018 buy was Marathon Petroleum: 220,704 shares worth $13M.
  • WS Management added most to Tesla in Q4 2018, an estimated $52.2M increase.
  • WS Management's biggest Q4 2018 reduction was Berkshire Hathaway Class B, cutting an estimated $178M.
  • WS Management fully exited The Mosaic Company in Q4 2018, selling an estimated $35.5M.
  • WS Management's ten largest holdings make up 64% of its $2.05B portfolio in Q4 2018.
  • WS Management opened 11 new positions and closed 9 in Q4 2018.
  • WS Management's portfolio value fell 33% quarter-over-quarter to $2.05B.

Based on WS Management's 13F filing for Q4 2018, filed 12 Feb 2019.